Abstract:BACKGROUND:To evaluate the surgical effect and prognostic factors of extended thymectomy for myasthenia gravis (MG) patients with thymomas. METHODS:Patients with MG with thymomas who underwent extended thymectomy at Peking University People's Hospital and Beijing Hospital between January 2010 and December 2018 were retrospectively enrolled. Patients were followed up by telephone or outpatient record review . Statistical analyses were performed using SPSS version 19.0. RESULTS:A total of 194 patients were included in this study. According to the Osserman classification, there were 56 type I, 52 type IIa, 67 type IIb, 14 type III, and five type IV. Video-assisted thoracoscopic surgery (VATS) thymectomies were performed in 137 patients, and transthymectomies in 57 patients. The average operation time was 136.6 ± 46.5 minutes, average blood loss was 129.3 ± 287.4 mL, and average postoperative stay was 8.3 ± 7.4 days. A total of 170 patients (87.6%) were successfully followed up. The median follow-up period was 45 months, and the five-year overall survival (OS) rate was 81.9%. Cox regression analysis demonstrated that age, Masaoka stage, and recurrence were prognostic factors of OS. Tumor recurrence tended to occur in patients with Masaoka stage III + IV, and age was a protective factor. A total of 20 patients experienced postoperative myasthenic crisis (POMC). Univariate analysis indicated that presence of bulbar symptoms, surgical procedure, and blood loss were risk factors for POMC, but multivariate analysis only indicated the presence of bulbar symptoms as an independent risk factor. A total of 162 patients were evaluated for post intervention MG status. A total of 55 patients achieved complete stable remission; the overall effective rate was 84.5%. Older patients and those with B-type thymomas had a lower probability of achieving complete stable remission. Efficacy was similar in patients who underwent VATS or the transsternal procedure. CONCLUSIONS:Age, Masaoka stage, and recurrence were prognostic factors of OS. Presence of bulbar symptoms was an independent risk factor for POMC. Age and World Health Organization classification influence the postoperative effect of MG. KEY POINTS:Significant findings of the study Age, Masaoka stage, and recurrence were prognostic factors of OS for MG with thymomas. The presence of bulbar symptoms was an independent risk factor for POMC. Age and World Health Organization classification may influence the postoperative effect of MG. What this study adds Our study had a relatively large sample size of MG patients with thymomas only. We emphasize the analysis of the postoperative effect of MG and overall survival for these patients, which is a complement to previous studies.

Clinical Analysis of 198 Cases of Myasthenia Gravis Patients with Thymectomy

[Results of Myasthenia Gravis Treated with Thymectomy].

Surgical effect and prognostic factors of myasthenia gravis with thymomas.

Evaluation of a Histogenetic Classification for Thymomas

Long-term Outcome after Thymectomy for Myasthenia Gravis and Analysis of Prognostic Factors

MYASTHENIA GRAVIS AND THYMECTOMY

Clinical Study on the Prognosis of Patients with Thymoma with Myasthenia Gravis

Descriptive analysis of therapeutic outcomes between thoracoscopic and transsternal thymectomy in myasthenia gravis patients from 2011 to 2021

Clinical features of thymoma with and without myasthenia gravis

[Relationship between thymectomy and syndrome differentiation-typing treatment of myasthenia gravis]

Influence of concomitant thymoma on effect of thymectomy for myasthenia gravis

Prognostic Analysis of Thymoma-Associated Myasthenia Gravis (MG) in Chinese Patients and Its Implication of MG Management: Experiences from a Tertiary Hospital

Surgical Therapy for Thymomas or Thymoma-Associated Myasthenia Gravis

Clinicopathological predictors of postoperative long-term myasthenic status in resected thymoma with myasthenia gravis

Factors Contributing to Myasthenic Crisis after Thymectomy—A Multivariate Analysis Study

Thymoma With Myasthenia Gravis: A Study of Two Cases

Perioperative risk factors for occurrence of myasthenia gravis after thymectomy in patients with thymoma.

Clinical Significance of Relationship Between the Myasthenia Gravis and the WHO Histological Type & Masaoka Clinical Stages of Thymoma

Childhood-Onset Myasthenia Gravis Patients Benefited from Thymectomy in a Long-Term Follow-up Observation

Stoical therapy and pathological analysis of thymoma

Thymectomy in the management of myasthenia gravis